<DOC>
	<DOCNO>NCT01586962</DOCNO>
	<brief_summary>This open label , in-use study ass warm sensation , acceptability local tolerability paracetamol 500 mg + pseudoephedrine 30 mg syrup , give single dose subject suffer symptom upper respiratory tract infection . The purpose evaluate acceptability concern warm sensation effect potential benefit target population . The primary objective ass warm sensation cause excipient IFF flavor 316 282 , syrup contain paracetamol 500 mg + pseudoephedrine 30 mg per 30 ml syrup . The syrup contain ( 0.15 % w/v ) warm flavor . The Secondary Objectives ass subject acceptability syrup safety tolerability syrup . The study run fifty-six ( 56 ) subject suffer symptom upper respiratory tract infection ( URTI ) 7 day less , e.g . nasal congestion associate cold flu symptom pain , headache and/or fever . Subjects must one symptom per category : 1. mild moderate body pain , headache , fever sore throat 2. nasal congestion ( block nose ) without rhinorrhea ( runny nose ) sneeze Adolescents include study population</brief_summary>
	<brief_title>Warming Sensation Intensity Acceptability Flavour , Local Tolerability Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup Patients Suffering URTI</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Subject must one symptom per category ( see also screen assessment cold symptom , section 6.1 ) : mild moderate body pain , headache , fever sore throat nasal congestion ( block nose ) without rhinorrhea ( runny nose ) sneeze 1 . Baseline sore throat pain severe intensity , e.g . rat 3 4point ordinal scale ( 0=not present , 1= mild , 2=moderate , 3=severe ) 2 . Baseline dry cough severe intensity , e.g . rat 3 4point ordinal scale ( 0=not present , 1= mild , 2=moderate , 3=severe ) 3 . Subject productive cough . 4 . History hypersensitivity study drug list excipients drug similar chemical class 5 . Subjects allergic asthma . 6 . Use inhaler , medicate confectionary , throat lozenge , throat pastille , spray , product demulcent property chew gum boil sweet mint , 6 hour prior dose . 7 . Use medication sore throat contain local anaesthetic within 6 hour prior dose . 8 . Use paracetamol , NSAID oral nasal decongestant within 6 hour prior dose . 9 . Use substance abuse antihistamine within 24 hour dose . 10 . Drinking tea , coffee caffeinated beverage 1 hour prior dose . 11 . Suffering hepatic severe renal impairment , hypertension , hyperthyroidism , diabetes , heart disease acute chronic medical condition , opinion investigator , would put subject high risk affect conduct and/or result study . 12 . Use antidepressant , monoamine oxidase inhibitor betablocking drug 28 day prior dose 13 . A history alcohol abuse subject admit regular consumption alcohol excess recommend weekly limit 21 unit female 28 unit male . 14 . Subject current smoker â‰¥10 cigarette per day ( report equivalent smoke habit use tobacco product ) . 15 . Subject smoke chewed tobacco product within 12 hour dose . 16 . History malignancy organ system ( localize basal cell carcinoma skin ) , treat untreated , within past 5 year , regardless whether evidence local recurrence metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>paracetamol</keyword>
	<keyword>pseudoephedrine</keyword>
	<keyword>syrup</keyword>
	<keyword>upper respiratory tract infection</keyword>
</DOC>